Log in or Sign up for Free to view tailored content for your specialty!
Gastroenterology News

Tremfya’s FDA win as fully subcutaneous option for Crohn’s may pave way to eclipse Stelara
The FDA has approved Tremfya as the “first and only” interleukin-23 inhibitor that offers both IV and fully subcutaneous induction options for the treatment of moderately to severely active Crohn’s disease, Johnson & Johnson reported.
Cancer surgeon runs the globe to raise testicular cancer awareness

Clark Gamblin, MD, MS, MBA, ran “on the moon” in Antarctica, under hang gliders in South Africa, and next to a starlit ocean in Australia.
Q&A: AMA president discusses fifth straight year of Medicare physician payment cuts

Physicians treating Medicare patients are staring down the barrel of five consecutive years of cuts to their reimbursement rates.
Log in or Sign up for Free to view tailored content for your specialty!
AGA stuck in neutral on AI-assisted colonoscopy guidance; ‘close tradeoff’ of cost/benefit

The AGA reported that it could not issue a recommendation for or against the use of computer-aided detection in colonoscopy due to “very low certainty of evidence” and “the close tradeoff between the desirable and undesirable effects.”
Biomarkers identified by machine learning could assist in diagnosing liver diseases

Machine learning may help identify biomarkers and develop predictive models that could assist in the diagnosis of metabolic dysfunction-associated steatotic liver disease and hepatic fibrosis, researchers reported.
‘Medicine is in crisis’: Future of dermatology relies on telehealth

It has been 5 years since the start of the COVID-19 pandemic, which forced many providers to embrace telehealth.
Etrasimod can be safely used alongside opioids, antidepressants in ulcerative colitis

Using etrasimod with opioids or antidepressants did not increase risk for serotonin syndrome-associated adverse events among patients with ulcerative colitis, according to a study published in United European Gastroenterology Journal.
Innovative surgery ‘changes the game’ for colorectal cancer that metastasizes to liver

Barclay Missen had resigned himself to hospice care.
‘No beneficial effects’ from simvastatin plus rifaximin for decompensated cirrhosis

The addition of simvastatin plus rifaximin to standard therapy did not improve outcomes among patients with decompensated cirrhosis who were at high risk for clinical complications, according to a study published in JAMA.
Study: Live vaccines safe, effective in pediatric transplant recipients

Most pediatric transplant recipients who received live-attenuated viral vaccines after transplant developed protective antibodies that persisted for up to a year after vaccination with no significant safety events, researchers found.
-
Headline News
Societies take stand against off-brand GLP-1s over safety concerns
March 17, 202515 min read -
Headline News
THA stem design may have a larger impact on periprosthetic fracture risk vs. cement use
February 06, 20251 min read -
Headline News
Self-perceived stress linked to cryptogenic ischemic stroke in young women
March 14, 20253 min read
-
Headline News
Societies take stand against off-brand GLP-1s over safety concerns
March 17, 202515 min read -
Headline News
THA stem design may have a larger impact on periprosthetic fracture risk vs. cement use
February 06, 20251 min read -
Headline News
Self-perceived stress linked to cryptogenic ischemic stroke in young women
March 14, 20253 min read